Matrix Conditions and KLF2-Dependent Induction of Heme Oxygenase-1 Modulate Inhibition of HCV Replication by Fluvastatin
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Matrix Conditions and KLF2-Dependent Induction of Heme Oxygenase-1 Modulate Inhibition of HCV Replication by Fluvastatin
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 5, Pages e96533
Publisher
Public Library of Science (PLoS)
Online
2014-05-07
DOI
10.1371/journal.pone.0096533
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study
- (2013) Line D. Rasmussen et al. PLoS One
- Hepatitis C virus resistance to protease inhibitors
- (2011) Philippe Halfon et al. JOURNAL OF HEPATOLOGY
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: Mechanism for the antiviral effects of heme oxygenase?
- (2010) Zhaowen Zhu et al. HEPATOLOGY
- Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells
- (2010) Jörg Schrader et al. HEPATOLOGY
- Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study
- (2010) L. Milazzo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cellular and molecular biology of HCV infection and hepatitis
- (2009) Hengli Tang et al. CLINICAL SCIENCE
- Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice
- (2009) Zeyu Liu et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response
- (2009) Elisabeth Lehmann et al. HEPATOLOGY
- Statins potentiate thein vitroanti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development
- (2009) Leen Delang et al. HEPATOLOGY
- Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis
- (2009) Savino Bruno et al. HEPATOLOGY
- An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads
- (2009) Hitomi Sezaki et al. INTERVIROLOGY
- Do statins reduce hepatitis C RNA titers during routine clinical use?
- (2009) Kimberly A Forde et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Fluvastatin Inhibits Hepatitis C Replication in Humans
- (2008) Ted Bader et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Hepatitis C Virus Infection and Hepatocellular Carcinoma
- (2008) Wojciech Blonski et al. Clinics in Liver Disease
- Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication
- (2008) Tohti Amet et al. MICROBES AND INFECTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now